In AOM-DSS, PD-1 mice were significantly more susceptible to DSS-mediated weight loss during the first treatment cycle, but susceptibility was reduced in the third treatment cycle as compared to WT cohorts (SI Appendix, Fig. S6A). The gene discussed is PDCD1; the disease is infectious otitis media.